Risankizumab improves PsA

Nat Rev Rheumatol. 2022 Mar;18(3):127. doi: 10.1038/s41584-022-00751-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Humans
  • Psoriasis*

Substances

  • Antibodies, Monoclonal
  • risankizumab